Condensed Consolidated Statement of Stockholders' Equity/(Deficit) (Unaudited) - USD ($)	Common Stock [Member]	Preferred Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Total
Balance at Dec. 31, 2022	$ 677	$ 175	$ 45,465,077	$ (34,112,810)	$ 11,353,119
Balance, shares at Dec. 31, 2022	677,221	175,000
Sale and issuance of common stock, net	$ 71		312,381		312,452
Sale and issuance of common stock, net, shares	71,499
Effect of reverse stock split round lot shares	$ 1,489		(1,489)
Effect of reverse stock split round lot shares, shares	1,488,615
Warrant inducement and exercise of 2,988,687 repriced common stock warrants at $1.10 per share	$ 2,989		3,284,567		3,287,556
Warrant inducement and exercise of 2,988,687 repriced common stock warrants at $1.10 per share, share	2,988,687
Warrant inducement offering costs and fees			(453,756)		(453,756)
Exercise of prefunded common stock warrants at $0.01 per share	$ 615		5,535		6,150
Exercise of prefunded common stock warrants, shares	615,000
Common stock issued as compensation	$ 34		25,950		25,984
Common stock issued as compensation, shares	34,241
Net loss				(3,610,929)	(3,610,929)
Sale of 615,000 pre-funded common stock warrants $4.36 per share, exercise price of $0.01			2,681,400		2,681,400
Prefunded common stock warrant offering costs and fee			(529,324)		(529,324)
Balance at Sep. 30, 2023	$ 5,875	$ 175	50,790,341	(37,723,739)	13,072,652
Balance, shares at Sep. 30, 2023	5,875,263	175,000
Balance at Jun. 30, 2023	$ 749	$ 175	47,929,533	(34,930,069)	13,000,388
Balance, shares at Jun. 30, 2023	748,720	175,000
Effect of reverse stock split round lot shares	$ 1,488		(1,488)
Effect of reverse stock split round lot shares, shares	1,488,615
Warrant inducement and exercise of 2,988,687 repriced common stock warrants at $1.10 per share	$ 2,989		3,284,567		3,287,556
Warrant inducement and exercise of 2,988,687 repriced common stock warrants at $1.10 per share, share	2,988,687
Warrant inducement offering costs and fees			(453,756)		(453,756)
Exercise of prefunded common stock warrants at $0.01 per share	$ 615		5,535		6,150
Exercise of prefunded common stock warrants, shares	615,000
Common stock issued as compensation	$ 34		25,950		25,984
Common stock issued as compensation, shares	34,241
Net loss					(2,793,670)
Balance at Sep. 30, 2023	$ 5,875	$ 175	50,790,341	(37,723,739)	13,072,652
Balance, shares at Sep. 30, 2023	5,875,263	175,000
Balance at Dec. 31, 2023	$ 9,005	$ 200	51,546,448	(47,481,836)	4,073,817
Balance, shares at Dec. 31, 2023	5,879,920	200,000
Sale and issuance of common stock, net	$ 673		301,002		301,675
Sale and issuance of common stock, net, shares	673,382
Compensation expense – officers – deferred comp – related party			492,189		492,189
Issuance of Common Stock in connection with the Amended Convertible Note Payable	$ 223		99,777		100,000
Issuance of Common Stock in connection with the Amended Convertible Note Payable, shares	223,214
Issuance of Common Stock in connection with Amended VGR working capital loan - August 2024	$ 167		74,833		75,000
Issuance of Common Stock in connection with Amended VGR working capital loan August 2024, shares	167,410
Issuance of Common Stock in connection with Amended VGR working capital loan - September 2024	$ 223		99,777		$ 100,000
Issuance of Common Stock in connection with Amended VGR working capital loan September 2024, shares	223,214
Warrant inducement and exercise of 2,988,687 repriced common stock warrants at $1.10 per share, share					2,988,687
Series D Convertible Preferred Stock issued in connection with two amended Revenue Interest Agreements and subsequently converted to Common Stock	$ 2,233	$ 22	728,563		$ 730,818
Series D Convertible Preferred Stock issued in connection with two amended Revenue Interest AgreementsSeries D Convertible Preferred Stock issued in connection with two amended Revenue Interest Agreements, shares	2,232,143	22,144
Net loss				(9,702,239)	(9,702,239)
Balance at Sep. 30, 2024	$ 12,524	$ 222	53,342,589	(57,184,075)	(3,828,740)
Balance, shares at Sep. 30, 2024	9,399,283	222,144
Balance at Jun. 30, 2024	$ 9,005	$ 333	53,967,072	(55,436,118)	(1,459,708)
Balance, shares at Jun. 30, 2024	5,879,920	333,334
Conversion of Series D Preferred Stock to Common Stock	$ 2,232	$ (111)	786,064		788,186
Conversion of Series D Preferred Stock to Common Stock, shares	2,232,143	(111,190)
Sale and issuance of common stock, net	$ 673		301,002		301,675
Sale and issuance of common stock, net, shares	673,382
Compensation expense – officers – deferred comp – related party			(1,985,936)		(1,985,936)
Issuance of Common Stock in connection with the Amended Convertible Note Payable	$ 223		99,777		100,000
Issuance of Common Stock in connection with the Amended Convertible Note Payable, shares	223,214
Issuance of Common Stock in connection with Amended VGR working capital loan - August 2024	$ 167		74,833		75,000
Issuance of Common Stock in connection with Amended VGR working capital loan August 2024, shares	167,410
Issuance of Common Stock in connection with Amended VGR working capital loan - September 2024	$ 223		99,777		100,000
Issuance of Common Stock in connection with Amended VGR working capital loan September 2024, shares	223,214
Net loss					(1,747,957)
Balance at Sep. 30, 2024	$ 12,524	$ 222	$ 53,342,589	$ (57,184,075)	$ (3,828,740)
Balance, shares at Sep. 30, 2024	9,399,283	222,144